KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Gains from Investment Securities (2016 - 2026)

Biogen has reported Gains from Investment Securities over the past 18 years, most recently at $20.5 million for Q1 2026.

  • For Q1 2026, Gains from Investment Securities rose 150.12% year-over-year to $20.5 million; the TTM value through Mar 2026 reached $53.7 million, up 120.24%, while the annual FY2025 figure was -$19.3 million, 87.91% up from the prior year.
  • Gains from Investment Securities for Q1 2026 was $20.5 million at Biogen, up from $14.4 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $503.7 million in Q3 2022 and troughed at -$513.3 million in Q4 2022.
  • A 5-year average of -$6.5 million and a median of $13.2 million in 2025 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 1543.01% in 2023 and later crashed 2582.0% in 2024.
  • Year by year, Gains from Investment Securities stood at -$513.3 million in 2022, then skyrocketed by 101.95% to $10.0 million in 2023, then crashed by 2582.0% to -$248.2 million in 2024, then skyrocketed by 105.8% to $14.4 million in 2025, then soared by 42.36% to $20.5 million in 2026.
  • Business Quant data shows Gains from Investment Securities for BIIB at $20.5 million in Q1 2026, $14.4 million in Q4 2025, and $5.6 million in Q3 2025.